Clin2
NCT07490327Likely a fitNot yet recruiting

Testing a dutasteride scalp solution for male hair loss

Androgenetic Alopecia

Part of Skin clinical trials.

This trial tests a new topical solution containing dutasteride to treat male pattern baldness. It aims to see if applying the medication directly to the scalp can help regrow hair with fewer side effects than pills.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
30 people
Ages
19 years to 55 years
Study type
Interventional

Who can take part

  • You are a man between 19 and 55 years old.
  • You have been diagnosed with male pattern baldness.
  • You are in overall good health (no major medical problems).
  • You have not used hair-growth medications like finasteride, dutasteride, or minoxidil in the past 6 months.
  • You have not had a hair transplant or scalp surgery before.
  • You do not have other scalp conditions like psoriasis or eczema.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06916793Not yet recruiting· Phase 3
Study of a new hair loss treatment for men

This study tests an experimental medication (CKD-843) for men with male pattern baldness. It aims to see if the treatment is safe and effective for regrowing hair.

Seoul
NCT07618195Recruiting· Phase 1/Phase 2
Testing EPI-001 for male and female pattern hair loss

This study tests an experimental treatment called EPI-001 for androgenetic alopecia—the most common type of hair loss affecting men and women. Researchers will measure how well it works by tracking hair growth over time using special photography and scalp analysis.

Seoul, Seoul
NCT04594018Recruiting· Phase 3
Test a hair lotion for male pattern hair loss

This Phase 3 study tests whether a specific hair lotion works and is safe for men with male pattern hair loss. It also checks that results are consistent while you keep similar hair care and avoid certain other hair-loss treatments.

Osasco, São Paulo
NCT06501924Not yet recruiting· Phase 3
Study of two new treatments for hair loss

This study tests two new topical treatments (DA-002 and DA-005) for hair loss in people with pattern baldness. The goal is to see if they can help hair grow back.

NCT06590779Not yet recruiting
Studying a cosmetic treatment for hair loss in men

This trial tests a cosmetic anti-hair loss product in men with early to moderate male pattern baldness. It looks at how well the product works and if it can help slow or reduce hair loss.

NCT07529977Not yet recruiting· Phase 3
Oral Minoxidil for Male Hair Loss Treatment

This trial tests a new oral (pill) form of minoxidil to help regrow hair in men with male-pattern baldness. Minoxidil is a known hair-growth medication, and this study evaluates whether taking it as a pill works safely and effectively.

Hear when a new Androgenetic Alopecia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.